PRURITIS
Clinical trials for PRURITIS explained in plain language.
Never miss a new study
Get alerted when new PRURITIS trials appear
Sign up with your email to follow new studies for PRURITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill tested to tame uncontrollable hives
Disease control CompletedThis study tested an oral medication called povorcitinib for adults with chronic spontaneous urticaria (long-lasting, unpredictable hives) that standard antihistamines could not control. The goal was to see if different doses of the drug could safely reduce hive and itch severity…
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New shot targets debilitating itch of skin condition
Symptom relief CompletedThis study tested whether an injectable drug called vixarelimab (KPL-716) could safely reduce severe itching and improve skin lesions in adults with prurigo nodularis. About 240 participants with moderate to severe symptoms received either the drug or a placebo for 8 to 16 weeks …
Matched conditions: PRURITIS
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC